Some argue the current system of subsidising drugs in Australia needs changing to accommodate new cancer therapies. But two recent drug listings show the current system is working perfectly well.
Rigor académico, oficio periodístico
Artículos sobre PBAC
Mostrando todos artículos
Intuitively, it might seem desirable to speed up access to medicines. But this means more drugs will be approved that may subsequently prove unsafe or ineffective.
Most of us would agree that cancer drugs should be listed on the PBS, no matter how dear. But our health system can’t afford all of them. How then are decisions about which drugs to subsidise made?
Hope, fear, and desperation, along with the unique characteristics of the cancer drug market, create a “perfect storm” that continues to drive up prices for cancer drugs.
Decisions about public subsidies for high-cost drugs are naturally quite complex. And while patients have increasingly been given a voice in the process, the views of the wider community have generally…
A government-appointed committee makes a recommendation that would save taxpayers $260 million within a year, but it’s ignored. And people at risk of heart attacks lose out. Let me explain via a ripping…
HEALTH RATIONING – a series which examines Australia’s rising health costs and the tough decisions governments must make to rein them it. Any mention of the “R” word in health care immediately brings to…
The Australian government introduced a controversial delay to the approval process for subsidised medicines last year, in an attempt to cut costs. We decided to examine the timelines of the approval process…
Recent news reports say the free whooping cough vaccine for parents to protect newborns will be discontinued because it is not effective. Parents who’ve been told this is an important step to protect their…
Boehringer Ingelheim, manufacturer of the expensive anti-clotting drug dabigatran, has initiated a lobbying campaign to get it listed on the Pharmaceutical Benefits Scheme (PBS). The company’s efforts…
Any parent who watches kids’ weekend footy knows that if the ref misses a breach of the rules, merry hell breaks loose. But referees are human and sometimes make errors. We forgive the odd one pretty quickly…
Principales colaboradores
-
Professor of Bioethics, Macquarie University
-
Macquarie University Research Fellow, Macquarie University
-
Dean, University of Wollongong
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Professor of Health Economics, The University of Melbourne
-
Professor and Director for the National Centre for Immunisation Research and Surveillance of Vaccine, University of Sydney
-
Professor of Health Economics, Monash University
-
Professor of Health Economics, Deputy Director of CHERE, University of Technology Sydney
-
Senior lecturer, health economics, University of Sydney
-
Professor of Health Economics, University of Technology Sydney
-
Research Fellow and PhD candidate School of Public Health, University of Sydney
-
Senior Research Fellow, University of Technology Sydney
-
PhD Candidate, NHMRC Clinical Trials Centre and Clinical Lecturer in Medicine, University of Sydney
-
Research Fellow, Flinders University
-
Professor of Health Economics, Flinders University
